Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Pharmacists Ranked 5th in FY2002 Honesty/Ethics in Profession Poll
July 8, 2002
- Revised Bill of Health Insurance Law Approved by Lower House
July 8, 2002
- Iwaki Launches Mechanical Ventilators
July 8, 2002
- 1st-Class Products Invite 1st-Class People:Dr Aoki of Fujisawa
July 8, 2002
- REGULATORY NEWS IN BRIEF
July 8, 2002
- Korosho Compiles Report on Healthcare Devices
July 8, 2002
- BULLETIN
July 8, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 8, 2002
- PRESS SEMINAR
July 8, 2002
- Novartis Aims at \70 Bil. Sales of Diovan in 2004
July 8, 2002
- Candesartan Reduces Risk of Non-fatal Stroke in the Elderly
July 8, 2002
- Wako Pure Chemical Starts Contract DNA Sequencing Services
July 8, 2002
- Shareholders' Meetings: Chugai's Merger with Roche Approved
July 8, 2002
- Lasofoxifene Highly Useful for Postmenopausal Diseases
July 8, 2002
- DIAGNOSTIC NEWS IN BRIEF
July 8, 2002
- BUSINESS NEWS IN BRIEF
July 8, 2002
- GL for Progressive Renal Disease Published by Korosho Study Group
July 8, 2002
- WORLD NEWS IN BRIEF
July 8, 2002
- Toyama Ties Up with Arrow of the UK to Develop Antifungals
July 8, 2002
- NCCRI, FeRx to Collaborate on Gene Therapy Research
July 8, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…